Page last updated: 2024-09-03

lysicamine and B16 Melanoma

lysicamine has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimoto, K; Matsuda, H; Matsumoto, T; Miki, H; Muraoka, O; Nakamura, S; Nakashima, S; Nishida, S; Oda, Y; Ogawa, K; Ohta, T; Sakuma, R; Tanabe, G; Yokota, N; Yoshikawa, M	1

Other Studies

1 other study(ies) available for lysicamine and B16 Melanoma

Article	Year
Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells. Bioorganic & medicinal chemistry, 2013, Feb-01, Volume: 21, Issue:3 Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flowers; Humans; Melanins; Melanoma, Experimental; Mice; Molecular Structure; Nelumbo; Plant Leaves; Structure-Activity Relationship	2013

Article

Year

Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells.

Bioorganic & medicinal chemistry, 2013, Feb-01, Volume: 21, Issue:3

Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flowers; Humans; Melanins; Melanoma, Experimental; Mice; Molecular Structure; Nelumbo; Plant Leaves; Structure-Activity Relationship

2013